Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.745 USD | -2.12% | -4.98% | -60.42% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.93M | Capitalization | 46.6M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.91 x |
P/E ratio 2024 * |
-0.4
x | P/E ratio 2025 * |
-0.6
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.5% |
Latest transcript on Bionano Genomics, Inc.
1 day | -4.02% | ||
1 week | -6.71% | ||
Current month | -31.43% | ||
1 month | -26.82% | ||
3 months | -38.62% | ||
6 months | -46.02% | ||
Current year | -59.73% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +6.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.7492 | -1.56% | 570 937 |
24-04-24 | 0.7611 | -4.19% | 797,490 |
24-04-23 | 0.7944 | +4.44% | 825,832 |
24-04-22 | 0.7606 | +1.41% | 871,068 |
24-04-19 | 0.75 | -4.73% | 987,981 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.73% | 46.6M | |
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
+0.23% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |
- Stock Market
- Equities
- BNGO Stock